Nuhey News

We talk about the MARKET

Research to Claim 12.8% CAGR for Thromboelastography Analyzer Market | The Market Reports

Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual’s hemostasis condition in a laboratory or point-of-care setting.

Due to the COVID-19 pandemic, the global Thromboelastography Analyzer market size is estimated to be worth US$ 281.1 million in 2021 and is forecast to a readjusted size of US$ 659.5 million by 2028 with a CAGR of 12.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Thromboelastography Analyzer market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Thromboelastography Analyzer landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The key players of Thromboelastography Analyzer include Haemonetics, WerfenLife, Framar Hemologix srl, Sienco, etc. The top two players of Thromboelastography Analyzer account for approximately 72% of the total market. North America is the largest market of Thromboelastography Analyzer accounting for about 33%, followed by Europe and Asia Pacific. In terms of Type, Conduit Techniques is the largest segment, with a share about 62%. In terms of Application, the largest segment is Hospital, followed by Maternal and Child Health Service.

This report focuses on Thromboelastography Analyzer volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Thromboelastography Analyzer market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and China, etc.

Request for a free sample or purchase this report at:

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Single and Double Channel
  • Four Channels
  • Others

Segment by Application

  • Hospital
  • Maternal and Child Health Service
  • Laboratory
  • Others

By Company

  • Haemonetics
  • Lepu Technology
  • Biomart
  • Medcaptain
  • Ud-Bio
  • Chongqing Nanfang
  • Witeye
  • Render
  • Guizhou Jinjiu Biotech
  • Chongqing Dingrun
  • Zhejiang Shengyu
  • Bio-Zircon
  • Werfenlife
  • Framar Hemologix Srl
  • Sienco

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)


Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479